The effects of urotensin II and urantide on forearm blood flow and systemic haemodynamics in humans.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  British Journal of Clinical Pharmacology

• Publication date

  2009-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1365-2125.2009.03475.xPMID 19843055PMCID PMC2780277
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Urotensin II in chronic liver disease: In vivo effect on vascular tone

  2008cited by this paper
• Skin vasodilator effect of exogenous urotensin‐II in hypertensives not exposed to antihypertensive medication

  2008cited by this paper
• State-dependent calcium mobilization by urotensin-II in cultured human endothelial cells.

  2008cited by this paper
• Urotensin-II receptor blockade with SB-611812 attenuates cardiac remodeling in experimental ischemic heart disease.

  2006cited by this paper
• Effect of exogenous urotensin-II on vascular tone in skin microcirculation of patients with essential hypertension.

  2005cited by this paper
• Urantide mimics urotensin-II induced calcium release in cells expressing recombinant UT receptors.

  2004cited by this paper
• Direct Actions of Urotensin II on the Heart: Implications for Cardiac Fibrosis and Hypertrophy

  2003cited by this paper
• Urotensin II Acts Centrally to Increase Epinephrine and ACTH Release and Cause Potent Inotropic and Chronotropic Actions

  2003cited by this paper
• Urantide: an ultrapotent urotensin II antagonist peptide in the rat aorta

  2003cited by this paper
• Molecular and pharmacological characterization of genes encoding urotensin‐II peptides and their cognate G‐protein‐coupled receptors from the mouse and monkey

  2002cited by this paper
• High plasma concentrations of human urotensin II do not alter local or systemic hemodynamics in man.

  2002cited by this paper
• Is urotensin‐II the new endothelin?

  2002cited by this paper
• Urotensin II evokes potent vasoconstriction in humans in vivo

  2002cited by this paper
• No effect on central or peripheral blood pressure of systemic urotensin II infusion in humans.

  2002cited by this paper
• Venous occlusion plethysmography in cardiovascular research: methodology and clinical applications.

  2001cited by this paper
• Potent vasodilator responses to human urotensin-II in human pulmonary and abdominal resistance arteries.

  2001cited by this paper
• Orphan‐receptor ligand human urotensin II: receptor localization in human tissues and comparison of vasoconstrictor responses with endothelin‐1

  2000cited by this paper
• Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14

  1999cited by this paper
• Cloning of the cDNA encoding the urotensin II precursor in frog and human reveals intense expression of the urotensin II gene in motoneurons of the spinal cord.

  1998cited by this paper
• Evaluation of three devices for self-measurement of blood pressure according to the revised British Hypertension Society Protocol: the Omron HEM-705CP, Philips HP5332, and Nissei DS-175.

  1996cited by this paper
• Cardiovascular actions of frog urotensin II in the frog, Rana catesbeiana.

  1995cited by this paper
• A novel putative neuropeptide receptor expressed in neural tissue, including sensory epithelia.

  1995cited by this paper
• Cloning and chromosomal mapping of three novel genes, GPR9, GPR10, and GPR14, encoding receptors related to interleukin 8, neuropeptide Y, and somatostatin receptors.

  1995cited by this paper
• Contraction of major artery segments of rat by fish neuropeptide urotensin II.

  1987cited by this paper
• Contraction of rat thoracic aorta strips induced by phorbol 12-myristate 13-acetate.

  1987cited by this paper
• Neurohormones from fish tails: the caudal neurosecretory system. I. "Urophysiology" and the caudal neurosecretory system of fishes.

  1985cited by this paper
• Urotensin II: a somatostatin-like peptide in the caudal neurosecretory system of fishes.

  1980cited by this paper

• Urotensin II system in chronic kidney disease

  2024cites this paper
• EXPLORATION OF THE UROCONTRIN A SCAFFOLD YIELDS NEW UROTENSINERGIC SYSTEM ALLOSTERIC MODULATOR AND COMPETITIVE ANTAGONISTS.

  2023cites this paper
• Urotensin II: an inflammatory cytokine.

  2019cites this paper
• The G Protein-Coupled Receptor UT of the Neuropeptide Urotensin II Displays Structural and Functional Chemokine Features

  2017cites this paper
• Autocrine Human Urotensin II Enhances Macrophage-Derived Foam Cell Formation in Transgenic Rabbits

  2015cites this paper
• International Union of Basic and Clinical Pharmacology. XCII. Urotensin II, Urotensin II–Related Peptide, and Their Receptor: From Structure to Function

  2015cites this paper
• CHARACTERIZATION OF INHIBITORS OF ALDEHYDE DEHYDROGENASE 2 IDENTIFIED THROUGH A HIGH-THROUGHPUT DOCKING APPROACH

  2013cites this paper
• The urotensin II receptor antagonist, urantide, protects against atherosclerosis in rats

  2013cites this paper
• Analysis of genetic variation within urotensin-II system in regulation of blood pressure and renal function

  2013cites this paper
• Discovery of a Novel Class of Covalent Inhibitor for Aldehyde Dehydrogenases*

  2011cites this paper
• Urotensin II, from fish to human

  2010cites this paper
• Untersuchung der proteolytischen Prozessierung von humanen Urotensin-Peptiden

  2010cites this paper
• Role of urotensin II in health and disease.

  2010cites this paper
• Endothelial progenitor cells & translational

  2009cites this paper
• Endothelial progenitor cells & translational research.

  2009cites this paper